Cardinal Health 2014 Annual Report Download - page 8

Cardinal Health, Inc. and subsidiaries
GAAP / Non-GAAP reconciliation
Fiscal year 2014 GAAP
Restructuring
and employee
severance
Amortization and
other acquisition-
related costs
Impairments and loss
on disposal of assets
Litigation
(recoveries) /
charges, net
Other
spin-o costs Non-GAAP
Operating earnings
Amount $1,885 $31 $223 $15 $(21) — $2,133
Growth rate 89% 4%
Diluted EPS from continuing operations
Amount $3.37 $0.06 $0.42 $0.03 $(0.04) — $3.84
Growth rate 247% 3%
Fiscal year 2013 GAAP
Restructuring
and employee
severance
Amortization and
other acquisition-
related costs
Impairments and loss
on disposal of assets
Litigation
(recoveries) /
charges, net
Other
spin-o costs Non-GAAP
Operating earnings
Amount $996 $71 $158 $859 $(38) — $2,046
Growth rate (44)% 10%
Diluted EPS from continuing operations
Amount $0.97 $0.13 $0.31 $2.39 $(0.07) — $3.73
Growth rate (68)% 16%
Fiscal year 2012 GAAP
Restructuring
and employee
severance
Amortization and
other acquisition-
related costs
Impairments and loss
on disposal of assets
Litigation
(recoveries) /
charges, net
Other
spin-o costs Non-GAAP
Operating earnings
Amount $1,792 $21 $33 $21 $(3) $2 $1,866
Growth rate 18% 13%
Diluted EPS from continuing operations
Amount $3.06 $0.04 $0.07 $0.04 $(0.01) — $3.21
Growth rate 12% 15%
The sum of the components may not equal the total due to rounding.
(in millions, except per common share amounts)
Important notice regarding forward-looking statements
This annual report contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments.
These statements may be identied by words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “will,” “should,” “could,” “would,” “project,” “continue,” “likely,” and similar
expressions, and include statements reecting future results or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could
cause actual results to dier materially from those projected, anticipated or implied. These risks and uncertainties include competitive pressures in Cardinal Health’s various lines
of business; the ability to achieve the expected benets from the generic sourcing joint venture with CVS Caremark; the frequency or rate of pharmaceutical price appreciation or
deation and the timing of generic and branded pharmaceutical introductions; the non-renewal or a default under one or more key customer or supplier arrangements or changes to
the terms of or level of purchases under those arrangements; the ability to achieve the anticipated results from the AccessClosure and Sonexus Health acquisitions; uncertainties due to
government health care reform including federal health care reform legislation; changes in the distribution patterns or reimbursement rates for health care products and services; the
eects of any investigation or action by any regulatory authority; and changes in the cost of commodities such as oil-based resins, cotton, latex and diesel fuel. Cardinal Health is subject
to additional risks and uncertainties described in Cardinal Health’s Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This presentation reects management’s
views as of August 13, 2014. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement.
Fiscal year 2014 GAAP
Walgreens
Revenue
Excluding
Walgreens
Revenue
Total Company $91,084 $3,310 $87,774
Growth rate (10)% 8%
Pharmaceutical Segment $80,110 $3,310 $76,800
Growth rate (12)% 8%
Fiscal year 2013 GAAP
Walgreens
Revenue
Excluding
Walgreens
Revenue
Total Company $101,093 $20,160 $80,933
Pharmaceutical Segment $91,097 $20,160 $70,937
6